Ultromics is unlocking the full potential of echocardiography for advanced heart disease detection and prediction. Discover the power of our groundbreaking AI SaaS platform.
WASE II: Ventricular Changes in Patients with Acute COVID-19 Infection: Follow-Up of The World Alliance Societies of Echocardiography (WASE-COVID) Study.
Automated Echocardiographic Detection of Severe Coronary Artery Disease using Artificial Intelligence.
Automated contouring of non-contrast enhanced echocardiograms result in similar estimates of left ventricular function to manually contoured contrast enhanced images in chemotherapy patients.
Fully automated quantification of LV regional wall motion from echocardiograms to detect myocardial infarction.
Fully automated left ventricular ejection fraction and global longitudinal strain predicts obstructive coronary artery disease in patients undergoing stress echocardiography: A multi-centre study.
WASE I: Echocardiography Predicts Death in Patients with Acute COVID-19 Infection: The World Alliance Societies of Echocardiography (WASE-COVID) Study.
See EchoGo in action
Upload 10 studies for free and experience EchoGo for yourself, or schedule a consultation with one of our clinical experts.